Author: Cazzola M. Di Perna F. Califano C. Vinciguerra A. D»Amato M.
Publisher: Academic Press
ISSN: 1094-5539
Source: Pulmonary Pharmacology & Therapeutics, Vol.12, Iss.4, 1999-08, pp. : 267-271
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Formoterol ± tiotropium bromide reduces COPD exacerbations
Inpharma, Vol. 1, Iss. 1558, 2006-01 ,pp. :
By Cazzola M. Centanni S. Regorda C. di Marco F. di Perna F. Carlucci P. Boveri B. Santus P.
Pulmonary Pharmacology & Therapeutics, Vol. 14, Iss. 1, 2001-01 ,pp. :
Budesonide/formoterol breathes QOL back into COPD patients
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 445, 2004-01 ,pp. :
Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. :
By Cazzola M. Marco F.D. Santus P. Boveri B. Verga M. Matera M.G. Centanni S.
Pulmonary Pharmacology & Therapeutics, Vol. 17, Iss. 1, 2004-02 ,pp. :